- Home
- KROS vs CCNE Comparison
KROS vs CCNE Comparison
Compare KROS & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- CCNE
- Stock Information
- Founded
- KROS 2015
- CCNE 1865
- Country
- KROS United States
- CCNE United States
- Employees
- KROS N/A
- CCNE N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- CCNE Major Banks
- Sector
- KROS Health Care
- CCNE Finance
- Exchange
- KROS Nasdaq
- CCNE Nasdaq
- Market Cap
- KROS 460.6M
- CCNE 595.8M
- IPO Year
- KROS 2020
- CCNE N/A
- Fundamental
- Price
- KROS $11.00
- CCNE $25.43
- Analyst Decision
- KROS Buy
- CCNE Hold
- Analyst Count
- KROS 11
- CCNE 1
- Target Price
- KROS $45.33
- CCNE $28.00
- AVG Volume (30 Days)
- KROS 2.1M
- CCNE 107.8K
- Earning Date
- KROS 02-26-2025
- CCNE 01-28-2025
- Dividend Yield
- KROS N/A
- CCNE 2.83%
- EPS Growth
- KROS N/A
- CCNE N/A
- EPS
- KROS N/A
- CCNE 2.39
- Revenue
- KROS $651,000.00
- CCNE $217,361,000.00
- Revenue This Year
- KROS $303.27
- CCNE N/A
- Revenue Next Year
- KROS N/A
- CCNE $17.74
- P/E Ratio
- KROS N/A
- CCNE $10.65
- Revenue Growth
- KROS 8037.50
- CCNE 0.09
- 52 Week Low
- KROS $9.78
- CCNE $17.74
- 52 Week High
- KROS $73.00
- CCNE $29.29
- Technical
- Relative Strength Index (RSI)
- KROS 24.79
- CCNE 54.01
- Support Level
- KROS $11.04
- CCNE $24.32
- Resistance Level
- KROS $11.99
- CCNE $26.15
- Average True Range (ATR)
- KROS 0.60
- CCNE 0.78
- MACD
- KROS 1.20
- CCNE 0.16
- Stochastic Oscillator
- KROS 43.99
- CCNE 72.31
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About CCNE CNB Financial Corporation
CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. In addition, the corporation provides wealth and asset management services, retirement plans and other employee benefit plans.